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Abstract Cytomegalovirus (CMV) is the most common
cause of congenital infection in developed countries and a
major cause of neurological disability in children. Although
CMV can affect multiple organs, the most important sequelae
of intrauterine infection are related to lesions of the central
nervous system. However, little is known about the pathogen-
esis and the cellular events responsible for neuronal damage in
infants with congenital infection. Some studies have demon-
strated that neural precursor cells (NPCs) show the greatest
susceptibility to CMV infection in the developing brain. We
sought to establish an in vitro model of CMV infection of the
developing brain in order to analyze the cellular events asso-
ciated with invasion by this virus. To this end, we employed
two cell lines as a permanent source of NPC, avoiding the
continuous use of human fetal tissue, the human SK-N-MC
neuroblastoma cell line, and an immortalized cell line of hu-
man fetal neural origin, hNS-1. We also investigated the effect
of the differentiation stage in relation to the susceptibility of
these cell lines by comparing the neuroblastoma cell line with
the multipotent cell line hNS-1. We found that the effects of
the virus were more severe in the neuroblastoma cell line.
Additionally, we induced hNS-1 to differentiate and evaluated
the effect of CMVin these differentiated cells. Like SK-N-MC
cells, hNS-1-differentiated cells were also susceptible to infec-
tion. Viability of differentiated hNS-1 cells decreased after
CMV infection in contrast to undifferentiated cells. In addi-
tion, differentiated hNS-1 cells showed an extensive cytopath-
ic effect whereas the effect was scarce in undifferentiated cells.
We describe some of the effects of CMV in neural stem cells,
and our observations suggest that the degree of differentiation
is important in the acquisition of susceptibility.
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Introduction
Human cytomegalovirus (HCMV), a member of the herpes
virus family, is a common pathogen in immunocompromized
patients and newborns. Excretion of viral particles in many
body fluids, including urine and saliva, among others, is re-
sponsible for HCMV spreading which results in 40 % sero-
positive adults in developed countries. The incidence of infec-
tion in developing countries is even higher, where almost
100 % of the population has been infected by adulthood
(Wynn and Khanna 2006; Ornoy 2007; Noyola et al.
2010). Congenital infection by HCMV has an incidence
between 0.8 and 2.6 % worldwide, and this infection is
the most frequent cause for developmental brain disor-
ders, including mental retardation and hearing loss.
Although most of the research about pathogenic mecha-
nisms of CMV in the brain has been performed on animals,
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an important limitation has been the strict host specificity of
CMVs, which requires the utilization of the corresponding
animal virus (Wynn and Khanna 2006). Furthermore, the clin-
ical manifestations on some animal models are different from
those observed in the human central nervous system (CNS)
(Woolf et al. 2007). Nevertheless, these animal models have
provided evidence that the highest CMV susceptibility in
CNS is presented by neural precursor cells (NPCs) (Tsutsui
et al. 2002). Infection of these cells might be the cause of
microcephaly and mental retardation since it has been ob-
served that murine CMV inhibits NPC proliferation and mi-
gration (Shinmura et al. 1997; Tsutsui et al. 2008). Further-
more, studies of functional neural cells after CMV infection,
though scarce, reveal that infected cells have altered intercel-
lular communication and deficient response to neurotransmit-
ters (Ho and van den Pol 2007).
In order to study NPC in vitro, it is necessary to isolate
them from embryonic tissue and maintain them in culture
under specific conditions to favor neural proliferation.
In vitro studies in which these cells were infected with human
CMV demonstrated that NPCs are highly permissive to CMV
infection and all types of viral proteins are expressed. In ad-
dition, cytopathic effect (CPE) in these cells at the multiplicity
of infection (MOI) of three plaque formation units (PFU) per
cell consisted in formation of syncytia, which can be the result
of viral cell to cell dissemination (Luo et al. 2008). Infection of
these cells may increase the apoptosis frequency and inhibit
neuronal and glia differentiation; however, this effect remains
controversial since it has also been reported that CMV infec-
tion may cause a spontaneous, premature, and abnormal NPC
differentiation (Odeberg et al. 2006, 2007; Luo et al. 2010).
Recently, the importance of the differentiation degree relat-
ed to the capacity of the virus to effectively infect the cells
during the first steps of the viral cycle was described. It was
shown that the concentration of heparan sulfate in the cell
surface, the presence of β1-integrin and vimentin, and the
nuclear pore density is important for the attachment, penetra-
tion, and internalization to the nucleus (Kawasaki et al. 2011).
In mouse models, it has been observed that embryonic stem
cells cannot be infected with CMVand they acquire suscepti-
bility through differentiation (Matsukage et al. 2006; Kawa-
saki et al. 2011). However, differentiated neurons are also
refractory to the infection and this may suggest that only dur-
ing a precise period during differentiation, the cells can be
infected (Cheeran et al. 2005).
Taking this into account, we aimed to establish an in vitro
model of CMV infection in NPC that could help clarify these
issues. In order to do so, we employed, as a permanent source
of NPC, two cell lines, avoiding the continuous use of human
fetuses, the human SK-N-MC neuroblastoma cell line and an
immortalized cell line of fetal origin hNS-1. The human neural
stem cell line hNS-1 was isolated from a 10.5-week-old hu-
man fetal tissue, immortalized using a retroviral vector
encoding v-myc fusion protein, and they proliferate in the
presence of growth factors (EGF and bFGF) (Villa et al.
2000, 2004). These cells are multipotent, and upon removal
of growth factors, they readily differentiated into neurons (β-
tubulin III+14.3±1.35 %), astrocytes (glial fibrillary acidic
protein (GFAP)+, 33.4±1.85), and oligodendrocytes
(Gal C <1 %) (Martinez-Serrano et al. 2001; Navarro-
Galve et al. 2005; Rubio et al. 2000; Villa et al. 2000,
2001, 2002). We also investigated the effect of the dif-
ferentiation degree related to the susceptibility of these
cell lines by comparing the neuroblastoma cell line with
the multipotent cell line hNS-1. We found that the ef-
fects of the virus were more severe in the neuroblasto-
ma cell line. Additionally, we induced hNS-1 to differ-
entiate and evaluated the effect of HCMV in these dif-
ferentiated cells. Like SK-N-MC cells, hNS-1-
differentiated cells were also susceptible, although not
in the same extent. We describe some effects of HCMV
in NPC, showing the importance of the differentiation
degree in the acquisition of susceptibility.
Methods
Cell culture and media The human NPC cell line hNS-1 was
generously donated from Centro de Biología Molecular
BSevero Ochoa,^ Madrid, Spain. These cells were grown in
poly-L-lysine (Sigma-Aldrich, St. Louis, MO)-coated plastic
flasks using a cell culture medium that contained DMEM-F12
(1:1, Gibco, Invitrogen Life Technologies, Carlsbad, CA) sup-
plemented with 0.6 % glucose, N2 (Life Technologies), 0.5 %
AlbuMAX I (Gibco), and human epidermal and fibroblast
growth factors (EGF/FGF-2, R&D Systems) as previously
described (Villa et al. 2000). For differentiation experiments,
hNS-1 cells were cultured 5 days without FGF-2 and EFG and
in the presence of fetal bovine serum 0.5 % (FBS, ATCC,
Rockville, MD). SK-N-MC cells (ATCC, Lot 4399800, Ma-
nassas, VA) were grown in MEM (ATCC) supplemented with
10 % FBS. Human foreskin fibroblasts were obtained from
primary culture and were grown in DMEM medium supple-
mented with 10 % calf serum (Gibco). MDCK cells (ATCC)
were grown in the same conditions as fibroblasts. Penicillin
and streptomycin were used (100 U/mL and 100 μg/mL) to
prevent culture contamination. For cells requiring serum, a
maintenance medium was used where the serum concentra-
tion was decreased to 2 % after CMV inoculation. All cell
cultures were grown at 37 °C in a 95 % humidity and a 5 %
CO2 atmosphere. Cell karyotyping and mycoplasma contam-
ination were assessed periodically.
Virus strain and infection Human CMV AD169 laboratory
strain was propagated in fibroblast cultures; cell-free viral
stocks were obtained from supernatants, frozen, and stored
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at −70 °C until use. Viral titers were determined by plaque
assay as previously described (Wentworth and French 1970).
Real-time quantification (LightCycler CMV LC Set vers 2.0)
of the viral stock was carried out, and cell lines and fibroblasts
were serum-starved and infected by virus adsorption for 2 to
24 h; then, maintenance medium was added. For differentia-
tion experiments, infection was carried out after 5 days of
growth factor starving.
Experimental design In all experimental approaches, the 0.01
MOI was administrated and a lower or a higher MOI, depend-
ing on the technique, was employed. In order tomonitor CMV
infection in NPC, we followed three procedures. First, we
periodically analyzed morphological changes through light
microscopy observation after cell infection at 0.01 and 0.1
MOI of CMV for 2 h. In addition, we confirmed infection
using a nested PCR to determine viral production in NPC
(SK-N-MC and hNS-1); we used MDCK and fibroblasts as
negative and positive controls of viral production, respective-
ly. In this case, we employed 2 h of infection with 10 DNA
viral copies per cell and supernatant aliquots of these infected
cells were drawn at 1, 4, 7, 11 and 14 days post-infection (dpi)
to test for the presence of CMV through PCR. Finally, we
demonstrated the presence of CMV within the infected cells
(0.1 MOI of CMV for 24 h) by detection of the viral glyco-
protein B (gB) by immunocytochemistry at 7 dpi. In this case,
a higher MOI was used because of the low detection of pos-
itive cells. We also analyzed cellular viability by trypan blue
assays and estimated proliferation using 3-(4,5-dimethyl-
th iazol -2-yl ) -5- (3-carboxymethoxyphenyl) -2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS)/phenazine
methosulfate (PMS) assay (Promega, Fitchburg, WI) at 1, 4,
and 7 dpi. NPC and fibroblasts were infected at 0.01 and 0.001
MOI of CMV for 24 h, controls corresponded to mock-
infected cells, and cisplatin (Sigma-Aldrich)-intoxicated cells
were used as a death control and inhibitor of proliferation
(2.5 μM for NPC and 50 μM for fibroblasts). Additionally,
carboxyfluorescein (CFSE, Invitrogen) assay was used to an-
alyze proliferation at 1, 4, and 7 dpi (0.01 MOI).
CPE on NPC Generally, the term CPE is attributed to diverse
pathological alterations in cells triggered by eukaryotic viruses
(Agol 2012). It includes the ability to injure or kill the infected
cells. In the case of CMV, intranuclear inclusions described like
a central nuclear body surrounded by a halo termed owl’s eyes
are the typical CPE (Ho 2008). In order to identify the CPE,
cells were seeded at 1×105 cells/well and, after attachment,
were infected for 2 h and kept in maintenance medium until
10–14 dpi. Cells were observed to evaluate morphological
changes including cytomegalic inclusions (owl’s eyes), vacu-
oles, cellular size changes, cellular soma granulations, nuclear
appearance variation, and the length of cellular prolongations.
We analyzed at least five random fields per well using an
inverted microscope Nikon TMS at×10 and×20 magnifica-
tions and performed at least three independent experiments.
Immunocytochemical evaluation NPC (5×104 cells/well) were
seeded in coverslips, and after attachment, they were infected
with 0.01 MOI of CMV. Coverslips were washed with
phosphate-buffered saline (PBS) and fixed with paraformalde-
hyde 4 % for 10 min; they were washed three times with a
washing buffer (1 % FBS and 0.025 % Triton X-100 in PBS)
for 10min and sodium borohydride (Sigma-Aldrich) for 10min,
followed by three washes with the washing buffer and incuba-
tion with a blocking buffer (10% FBS, 0.025%Triton X-100 in
PBS) for 2 h, and left overnight at 4 °C with the mouse mono-
clonal primary antibodies against viral gB (1:800, Serotec, Ra-
leigh, NC), nestin (1:1000, Santa Cruz Biotechnology, Dallas,
TX), and microtubule-associated protein 2 (MAP-2) (1:1000,
Sigma) or with the rabbit polyclonal primary antibody against
GFAP (1:1000, Dako, Mexico, DF). Coverslips were washed
three times with the washing buffer and incubated with the
polyclonal goat anti-mouse Cy3-conjugated (1:300, Abcam),
rabbit anti-mouse FITC-conjugated (1:300, Serotec) or goat
anti-rabbit Alexa-546-conjugated (1:300, Invitrogen) antibodies
for 2 h. Cell nuclei were counterstained with Hoechst 33258
(0.2 μg/mL, Invitrogen) or propidium iodide (5 μg/mL, Sigma)
for 5 min. Microscopic examination and photography of speci-
mens were performed in a Olympus BX41 epifluorescence mi-
croscope. The quantification of CMV-infected cells was carried
out in a BD FACSCalibur flow cytometer by detecting the per-
centage of gB-immunoreactive cells.
Viral production assay Onto six-well plates, 2×105 cells/well
were seeded, supernatant aliquots (two wells for each study
condition, 200 μL each) were taken, and cells were infected.
After 2 h of incubation, cells were washed with PBS and 4 mL
of maintenance medium was added. Aliquots were taken at
different dpi and preserved at −70 °C until use. Medium re-
position was done immediately before each sample was ob-
tained. Cells were trypsinized at 14 dpi and were processed
with the supernatants. Each sample was spiked with 5×104
SK-N-MC cells to homogenize the actin control. DNA extrac-
tion and nested PCR (described below) were carried out, and
electrophoretic products were photographed and analyzed by
densitometry with the program ImageJ (Wayne Rasband,
HIMH, NIH, free access http://rsbweb.nih.gov/ij/).
Nested PCR Viral DNA was extracted from culture superna-
tants (0.2 μL) as previously described (Monsivais-Urenda
et al. 2010). Outer (forward 5′-GTC AAA CAG ATT AAG
GTT CGA GTG G-3′, reverse 5′-TGTACT CAT TAC ACA
TTG TTT CCA CAC-3′) and inner (forward 5′-ACT GGC
GCC TTT AAT ATG ATG GG-3′, reverse 5′-GAG CAC
TGA GGC AAG TTC TGC-3′) primers were aimed to the
immediate early protein 1 gene of CMVand amplified a final
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380-bp fragment (Monsivais-Urenda et al. 2010). Another set
of primers (forward 5′-ACGGCT CCG GCATGT GCA AG-
3′ and reverse 5′-TGA CGA TGC CGT GCT CGA TG-3′)
were used in the same reactions as an internal control which
amplified β-actin gene (240 pb, Köhler 1995). For both PCRs,
0.06 UI/μLTaq (Vivantis Technologies Sdn Bhd, Selangor DE,
Malaysia) was utilized in a final volume of 12.5 μL per reaction.
In the first PCR, 0.5μmol/L of CMVouter primers, 0.075μmol/
L of β-actin primers, and 1 μL of DNAwere used, whereas in
the second reaction, 0.5 μmol/L of CMV inner primers,
0.1 μmol/L of β-actin primers, and 1 μL of the first reaction
were employed. PCR conditions were the same for both reac-
tions, beginning with DNA denaturalization at 94 °C for 5 min
and 30 amplification cycles (94 °C for 1 min, 60 °C for 1 min,
and 72 °C for 1 min) followed by a final extension of 10 min at
72 °C. Nested PCR products were observed after electrophoresis
in a 1.5 % agarose gel stained with ethidium bromide and
photographed using a Kodak Gel Logic 100 transilluminator.
The detection limit of this assay is 1×104 DNA copies/mL.
Trypan blue assay NPC and fibroblasts were seeded at 5×104
cells/well in 24-well plates. After attachment, the cells were
infected with CMVor exposed to cisplatin for 24 h. Viability
assays were performed using 0.05 % trypan blue in a cellular
suspension of 1 mL. After incubation for 5 min, dead (blue)
and live (colorless) cells were counted in a Neubauer chamber.
The percentage of viable cells was obtained from four repli-
cates of each condition, using three independent experiments.
MTS/PMS assay The proliferation assaywas performed using a
kit which determines the overall amount of metabolically active
cells through conversion of a tetrazolium salt to formazan which
is solubilized and determined spectrophotometrically at 490 nm.
In 96-well plates, 5×104 NPC and 2.5×104 fibroblasts were
seeded, and after attachment, the cells were infected with
CMV or exposed to cisplatin. At 1 and 7 dpi, 20 μL of a
MTS/PMS mix was added to each well and incubated at
37 °C for 2 h for NPC and 1 h for fibroblasts, and then, absor-
bance was measured in a BioTek ELx800 spectrophotometer.
Metabolic activity percentage was calculated through compari-
son with the average absorbance of the mock-infected control.
At least four replicates were performed for each condition in
three independent experiments.
CFSE assay NPCs were seeded at 2×105 cell/well in six-well
plates. Culture mediumwas removed, and 500 μL of PBS and
1 μL of CFSE (5 mM) were added. Cells in these conditions
were incubated in the dark for 10 min, and after this time,
2 mL of medium was added and removed immediately and
cells were maintained in incubation with growth medium until
the indicated times. Then, at the indicated days, cells were
trypsinized and suspended in p-formaldehyde 1 % and ana-
lyzed in a BD FACSCalibur flow cytometer.
Statistical analysis Data were expressed as mean±standard
deviation (SD) or median±interquartile range (IQR). If the
data meet the specifications, parametric assays were per-
formed, Student t test or ANOVA for multiple comparisons
with Bonferroni post hoc test. In order to analyze nonparamet-
ric data, Mann-Whitney U was used. A level of <0.05 was
considered significant. All data were analyzed in GraphPad
Prism 5.01.
Results
Productive infection rate in SK-N-MC is higher than in hNS-1
cells
In order to demonstrate HCMV protein expression in NPC
with the AD169 HCMV strain, infected cells in coverslips
were stained for the presence of the late viral gB at 7 dpi. In
addition, nestin antibody was used to show the NPC identity
(Fig. 1a). Quantification of the percentage of gB-
immunoreactive cells at 7 dpi showed that SK-N-MC cells
(95.4±2.7 %, n=4) are much more susceptible to be infected
with HCMV than hNS-1 cells (8.4±4.5 %, n=7) at an MOI of
0.1 (Fig. 1b). As gB results fromHCMV late gene expression,
this assay is an indirect verification of viral immediate-early
and early gene expression, since viral replication was efficient
and complete viral particle formation was inferred in these
cells. Additionally, we sought to investigate if these NPCs
can produce viral particles, so we performed a comparative
assay using fibroblasts in which viral propagation in vitro nor-
mally occurs (positive control). On the other hand, MDCK
cells were used as a negative control of viral production based
on its canine origin. The media from such cells were collected
at different dpi, and viral production was quantified by a
nested PCR. Aswe expected, inMDCK cells, viral production
was null (not shown), whereas SK-N-MC cells followed the
same behavior as fibroblasts. Even though viral production
was slightly lower at 1 dpi, it was similar to that of fibroblasts
in the last time points studied. On the contrary, viral produc-
tion was almost null in hNS-1-infected cells, showing that
these can be infected but they cannot actively replicate this
virus (Fig. 1c).
CPE of human CMV in NPCs
After HCMV infection in SK-N-MC cells, we observed an
important cellular loss and the development of viral
concentration-dependent CPE. In these cells, vacuole forma-
tion and presence of granulation were not as evident as they
were seen during fibroblast infection (not shown). SK-N-MC
cells infected with 0.1 MOI initially showed a loss of normal
morphology, since their multiple short-length cytoplasmic
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prolongations were lost (Fig. 2a) and the cells turned to a
rounded or fusiform shape after infection. At this viral con-
centration, the predominant effect was the formation of syn-
cytia that are described as multinuclear giant cells; these in-
creased in number and size as the infection progressed
(Fig. 2b, arrows). In some cases, we found intracellular inclu-
sions characterized by a rounded nucleus surrounded by a
halo, which are known as owl’s eyes (Ho 2008) (Fig. 2b,
arrowheads). The CPE of SK-N-MC cells infected with 0.01
MOI was very different. Starting on 4 dpi, some cells exhib-
ited cytoplasmic prolongations that suggest neural differenti-
ation. An increasing number of cells were observed as HCMV
infection progressed (Fig. 2c). At 10 dpi, however, the number
of this kind of cells decreased and syncytia formation was
noticed as had been observed with the other concentration
(not shown). Conversely, during HCMV infection of hNS-1
cells, we did not observe changes neither at 0.1 MOI nor at
0.01 MOI; only slight syncytia formation and scarce owl’s
eyes at advanced dpi were observed (Fig. 2d–f).
Viability of SK-N-MC decreases during CMV infection
whereas hNS-1 cells are resistant
Mock-infected and HCMV-infected cells were analyzed for
cellular viability in a trypan blue assay at 1 and 7 dpi. In
SK-N-MC cells, an increased cell death was demonstrated
with 0.01 MOI at 1 (68.8±7 %, p<0.05) and 7 dpi (61.4±
20 %, p<0.05), whereas with 0.001 MOI, any significant ef-
fect in cellular viability was noticed (73.7±3% at 1 dpi and 71
±16 % at 7 dpi) when compared against mock-infected cells
(84.15±2 % at 1 dpi and 90.9±4 %). On the other hand, hNS-
1 cells appeared to be resistant to CMV infection since we did
not observe any change in cellular viability with any of the
viral doses used (Fig. 3a).
Fig. 1 Viral production in SK-N-
MC is higher than in hNS-1 cells.
a Cells were seeded in coverslips,
fixed, and processed for immu-
nofluorescence using Abs for
nestin, a NPC marker (nuclei
were counterstained with Hoechst
33258) and for gB, a HCMV late
protein at 7 dpi with HCMV 0.1
MOI (nuclei were counterstained
with propidium iodide). Scale
bar, 50 μm. b Using flow cytom-
etry, the numbers of gB-positive
cells were quantified at 7 dpi with
0.1 MOI (mean percentage±SD,
n=at least three independent ex-
periments, ***p<0.001t test). c
NPC and fibroblasts were infect-
ed with 10 viral DNA copies/mL,
and supernatants were collected at
1, 4, 7, 11, and 14 dpi. Increase in
viral genetic material during in-
fection progression is shown
(*p<0.05, **p<0.01,
***p<0.001 vs 1 dpi for each cell
line). Each point represents me-
dian of two independent experi-
ments with at least three repli-
cates, and error bars correspond
to interquartile range
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Infected NPCs increased their metabolic activity early
during infection and modify proliferation according
to the infection progress
In order to assess if HCMV-infected NPCs have an effect in
proliferation, SK-N-MC and hNS-1 cells were either infected
with 0.01 and 0.001 MOI of HCMVor mock-infected. Cellu-
lar proliferation was quantified 1 and 7 dpi by a MTS/PMS
assay.We found a significant impact of CMVinfection on SK-
N-MC cells. At 1 dpi, we observed that cellular proliferation
increased in infected cells compared with that in mock-
infected cells (117.1±12 and 115.2±1.4 % activity related to
control for 0.001 and 0.1 MOI, respectively). Nevertheless,
this effect was reversed at 7 dpi when a clear proliferation
reduction was observed and it was even more pronounced
with the higher viral concentration (56.2±3.7 % for MOI of
0.001 and 30±11 % for MOI of 0.01, p<0.001) (Fig. 3b). In
the case of hNS-1 cells, we did not observe any change in
proliferation even with the highest viral concentration
employed (Fig. 3b). These contrasting results could reflect
the difference in susceptibility between these two NPCs. To
confirm that these changes indeed reveal the effect in cellular
Fig. 3 Viability of SK-N-MC decreases during HCMV infection where-
as hNS-1 cells are resistant. SK-N-MC and hNS-1 cells were infected
with MOI of 0.01 and 0.001 or mock-infected. a Trypan blue assay was
performed at 1 and 7 dpi (mean percentage±SD, n=4). b Metabolic
activity was analyzed at 1 and 7 dpi using a colorimetric assay where
metabolically active cells convert a tetrazolium salt to formazan, and then,
the absorbance at 490 nmwas recorded (mean percentage±SD, n=at least
three independent experiments). The differences were analyzed for statis-
tical significance using one-way ANOVA (*p<0.05, **p<0.01,
***p<0.001)
Fig. 2 Cytopathic effect of HCMV in NPC. Pictures shown are
representative of image series of SK-N-MC or hNS-1 cells mock-
infected or after infection with 0.01 MOI or 0.1 MOI at 7 dpi. a–c In
SK-N-MC cells, the predominant effect with 0.01 MOI was cytoplasmic
prolongations, whereas after infection with the higher viral concentration,
we observed syncytia formation (arrows) and cytoplasmic inclusions
(arrowheads). d–f In hNS-1, we did not observe any evident change, only
slight syncytia formation and scarce cytoplasmic inclusions. Scale bar,
50 μm
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proliferation and not only in metabolic activity, we also eval-
uated this parameter by CFSE dilution in cells infected with
the MOI of 0.01 and mock-infected cells. However, in infect-
ed SK-N-MC cells, we only found an increase in proliferation
at 4 dpi and any evident effect at 1 or 7 dpi. As the MTS/PMS
assay showed, the metabolic activity was higher at 1 dpi and
results in cellular division at 4 dpi as it is revealed in CFSE
assay; nevertheless, at 7 dpi, the cellular activity was dimin-
ished, but it does not affect proliferation (Fig. 4a). On the other
hand, an enhanced proliferation was evidenced in hNS-1 cells
at 4 and 7 dpi, although no effect was observed in the MTS/
PMS assay (Fig. 4b, c). This may be related to the lesser
susceptibility of these cells to the infection because after
4 dpi, the effects start to emerge.
Differentiation of hNS-1 cells makes them more susceptible
to HCMV infection
Since SK-N-MC has a more committed fate than hNS-1 cells,
it may explain their distinct susceptibility, and given that hNS-
1 cell line is multipotent, it can be induced to differentiate and
analyze if the differentiation degree modifies their capacity to
be infected and the effects of infection. Subsequently, hNS-1
cells were induced to differentiate during 5 days, in order to
produce some neural and glial progenitors, and then, they
were infected with HCMV at MOI of 0.01 and 0.1 or mock-
infected. At 7 dpi, it became evident that the CPE was more
pronounced in the differentiated cells, and we noticed syncytia
formation, some cytoplasmatic inclusions, and vacuoles
(Fig. 5a). Differentiated hNS-1 cells begin to express MAP-
2 (6.6±4.5 %) and GFAP (4.9±2.3 %), cellular markers of
neurons and astrocytes, respectively (Fig. 5b). At this time
point, the cells were infected and the percentage of cells ex-
pressing gB were higher (20.6±4.6 %, n=3, p<0.01) than in
the undifferentiated cells (Fig. 5c) with the MOI of 0.1 at
7 dpi. In contrast with the undifferentiated hNS-1, the viability
of the differentiated hNS-1 cells decreases with the progres-
sion of HCMV infection even at 1 (72.5±15 %) and 7 dpi
(61.5±6.7 %) (Fig. 5d). Whereas, the metabolic activity of
these infected cells decreases at 1 dpi (74.1±6.5 %, p<0.05)
and the effect is reverted at 7 dpi (Fig. 5e). Similarly, these
effects were observed in the proliferation assay, and we found
a decline in cellular division at 1 dpi (5±7.4 %), but this effect
is lost according to the infection progress (Fig. 5f). Indeed, we
did not expect a strong effect in proliferation, since these cells
were differentiating and only a remaining percentage con-
tinues in cell division.
Discussion
In congenital HCMV infection, the brain is the main infection
target and may cause significant damage to the developing
brain. It has been recently described that the most susceptible
cells inside the CNS are located in the ventricular and
subventricular zones containing NPCs (Cheeran et al. 2009;
Tsutsui 2009). Infection of NPCs may cause malformations
such as microcephaly and cerebellar hypoplasia and function-
al disorders like mental retardation and epilepsy (Tsutsui
Fig. 4 Proliferation of NPC
increases slightly during
infection. a SK-N-MC and b
hNS-1 cells were incubated in the
dark with CFSE 20 μM for
10 min; then, the cells were in-
fected with the MOI of 0.01 or
mock-infected. NPCs were col-
lected at 1, 4, and 7 dpi, and the
quantification of CFSE charge
was analyzed by flow cytometry
(median±IQR, n=4, **p<0.01,
***p<0.001 Mann Whitney U
test). c Representative histograms
of hNS-1 cells indicating the per-
centage of cellular division at
each time of infection for cells
infected with MOI 0.01 and
mock-infected. The median per-
centage is indicated in each plot
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Fig. 5 Differentiation of hNS-1
cells makes them more suscepti-
ble to HCMV infection. hNS-1
cells were induced to differentiate
during 5 days; then, they were
infected with HCMVat MOI of
0.01 and 0.1 or mock-infected. a
Differentiated and undifferentiat-
ed hNS-1 cells infected with
HCMVat 7 dpi showed CPE that
was more notable in differentiated
cells (cytoplasmic inclusions
shown by arrow heads and vacu-
oles shown by asterisks). b Dif-
ferentiated hNS-1 cells begin to
express MAP-2 and GFAP, cellu-
lar markers of neurons and astro-
cytes, respectively. Scale bar,
50 μm. c Expression of gB in
differentiated hNS-1 cells at 7 dpi
(mean percentage±SD, n=at least
three independent experiments,
**p<0.01t test). d In contrast
with the undifferentiated hNS-1,
the viability of the differentiated
hNS-1 cells decreases with the
progression of HCMV infection
(mean percentage±SD, n=
4, *p<0.05 t test). e By MTS/
PMS assay, it was determined that
the metabolic activity of these in-
fected cells decreases at 1 dpi and
the effect is null at 7 dpi (mean
percentage±SD, n=5, *p<0.05 t
test). f In the proliferation assay
using CFSE, we found a decline
in cellular division at 1 dpi, but
this effect is lost according to the
infection progress (median±IQR,
n=4, *p<0.05 Mann Whitney U
test)
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2009). The molecular mechanisms underlying pathogenic re-
sponses to HCMV infection of NPCs are poorly understood.
Increasing knowledge about how HCMV interferes with the
normal function of NPC is therefore of considerable interest
because of NPC’s role during development. Here, we have
used an in vitro model based on human NPC infection to
investigate these subjects. We employed the human cell lines
SK-N-MC and hNS-1 as a source of NPC. The SK-N-MC is a
naturally immortal cell line because it derives from a neuro-
blastoma, while hNS-1 cell line was genetically perpetuated
by transfection of the avian oncogen v-myc and it is condi-
tionally immortalized since it has a strict requirement for mi-
togens EGF and FGF-2 (Villa et al. 2000). The SK-N-MC cell
line is more committed to the neuronal fate than hNS-1 cells
which are multipotent and can produce neurons and glia
through differentiation (Villa et al. 2000). We confirmed
HCMV infection in these cell lines and analyzed cellular via-
bility and proliferation. In SK-N-MC cells, we found out that
low viral doses stimulated proliferation, increased their meta-
bolic activity, and induced differentiation; we also noticed that
CPE is dose-dependent in this cell line. In contrast, at the same
MOIs, hNS-1 cells could only be infected to a lower extent.
Scarce evidence of the infection was obtained since the im-
munoreactivity for gB of HCMV inside the cells was much
weaker than in SK-N-MC cells. In addition, no evidence of
cell death or modifications in metabolic activity were found,
although the proliferation rate increased at late days after in-
fection. Interestingly, after 5 days of differentiation, hNS-1
cells were highly infected showing thus an increased suscep-
tibility. The CPE was more pronounced, and viability, mito-
chondrial activity, and proliferation decreased while a higher
percentage of cells were found infected. These results suggest
that neurotoxicity mechanisms associated to HCMV infection
may be dependent on the differentiation stage of these NPCs.
The observation of syncytia formation after HCMV infec-
tion in SK-N-MC with the MOI of 0.1 is in agreement with
earlier reported findings (Luo et al. 2008). However, the tem-
poral course of these changes was different, which could be
attributed to HCMV doses. Syncytia formation has also been
reported in other cellular types, and it seems to be related to cell
fusion induced by viral glycoproteins present in the plasma
membrane (Belec et al. 1990; van Den Pol et al. 1999; Kinzler
and Compton 2005). On the other hand, when we infected SK-
N-MC with the MOI of 0.01, cellular prolongations were ob-
served suggesting cellular differentiation to a neuron-like mor-
phology, an unexpected finding since we did not add any other
stimulus that may account for these changes, and this normally
does not occur in an spontaneous way (Higgins et al. 2009).
This induction of differentiation is in agreement with the recent
observation of abnormal, spontaneous, and premature differen-
tiation of NPC induced by HCMV (Odeberg et al. 2006; Luo
et al. 2010). The virus concentrations that we used were much
lower than those in previous studies, what may explain the
delayed effect observed. In contrast with those reports, we
monitored the CPE in the cells for a more prolonged period
of time and observed syncytia formation as the infection
progressed. Altogether, these observations suggest that cellular
differentiation is stimulated in early stages of infection and that
cells tend to fuse forming syncytia as viral concentration in-
creases or time after infection progresses. A possible explana-
tion for this latter effect can be a distinct regulation of transcrip-
tion factors such as SOX2 which is related to embryonic de-
velopment and stem cell self-renewal and expression of some
receptors like EGFR as well as cytoskeleton components
(Jafferji et al. 2009; Luo et al. 2010). Nevertheless, the rele-
vance of HCMV-induced differentiation in the context of CNS
development and finding why it is reversed when viral concen-
tration increases are a matter for further investigation. In con-
trast with our findings in SK-N-MC cells, previous reports
showed a decrease in NPC differentiation to neurons and glia
after HCMV infection (Odeberg et al. 2006, 2007). Indeed, the
experimental methods used in these studies were different, and
since we did not induce differentiation, it occurred spontane-
ously. In addition, the virus concentrations employed were
higher in the studies of Odeberg et al. than the ones used in
the present work. In the case of hNS-1, we noticed a slight CPE
with some owl’s eyes and syncytia formation at advanced
stages post-infection, indicating that these cells are less suscep-
tible to HCMV infection which may be a consequence of their
fully undifferentiated state (hNS-1 is composed of neural stem
cells).
Viral particle production was monitored by the viral pro-
duction assay, through the increased presence of viral DNA in
the cell supernatants at different times post-infection. The lev-
el of detection of viral particles in the cell lines used here was
consistent with the results obtained using a different source of
NPC (Luo et al. 2008). However, it is dissimilar to those of
others who have reported that NPCs are fully permissive to the
infection, but few viral particles are released (Odeberg et al.
2006). We observed that viral production in SK-N-MC was
similar to the one in fibroblasts but not detectable in hNS-1.
This might reflect the variability of results obtained when
working with different NPC cultures. On the one hand, SK-
N-MC cells may resemble one cell type used (Luo et al. 2008)
whereas hNS-1may bemore similar to the other one (Odeberg
et al. 2006). Also, when we studied gB expression, we found
the majority of SK-N-MC cells being positive in immunocy-
tochemistry; however, only a low percentage of hNS-1 cells
were positively stained for gB. This might reflect their low
susceptibility to infection and may explain that viral produc-
tion could not be detected. Since gB is a product of late viral
genes, its presence reflects the capacity of the virus and cells
for viral replication.
HCMV infection induces cell death of SK-N-MC cells but
not of hNS-1 ones. Cell death induced by HCMV could be the
result of a necrotic or an apoptotic process since this assay
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does not indicate the involved mechanism (Cheeran et al.
2005; Odeberg et al. 2006). In addition, proliferation assays
showed a strong reduction in SK-N-MC proliferation at 7 dpi
with both HCMV concentrations. However, paradoxically, at
1 dpi, an increased metabolism was observed after HCMV
infection; this observation could also derive from an increase
in cellular activity due to viral stimulation of macromolecule
synthesis during viral replication, rather than an actual in-
crease in the number of cells. Indeed, in the proliferation assay
using CFSE, we only detected an increase in cellular division
at 4 dpi. It is consistent with a previous report of no change in
proliferation at 7 dpi using the MOI of 0.1 by the detection of
PCNA, a marker for proliferation; however, we showed a
previous contradictory induction of proliferation and metabol-
ic activity (Odeberg et al. 2007). It is believed that viruses
avoid cellular macromolecule production to elude immune
system activation. However, in contrast with other viruses, it
has been observed that HCMV stimulates cellular DNA,
RNA, and protein synthesis, perhaps because HCMVrequires
a protein that cannot be produced byHCMV (DeMarchi 1983;
Griffiths and Grundy 1987). As expected, cellular metabolism
decreased at 7 dpi because although immediate-early proteins
stimulate cellular function, early proteins interrupt this process
(Griffiths and Grundy 1987). In contrast, hNS-1 cells ap-
peared more resistant even than fibroblast in this MTS/PMS
assay and did not show any change in cellular viability, con-
sistent with the lack of viral production, as evidenced by DNA
detection. Nevertheless, even though some changes in meta-
bolic activity were detected, cellular proliferation increased at
4 and 7 dpi. This may represent a delayed effect which may be
a product of the low rate of infection of these cells. The re-
duced susceptibility to HCMV infection may be a matter of
cellular differentiation since hNS-1 cells can be considered
more undifferentiated cells than SK-N-MC ones. Of note,
some reports have shown that embryonic stem cells are resis-
tant to HCMV infection and that embryos acquire susceptibil-
ity during development (Tsutsui 2009). In order to test this
hypothesis, hNS-1 cells were differentiated for 5 days and
they were HCMV-infected. At this stage, some cells begin to
express GFAP and MAP-2, cellular markers of astroglia and
neurons, respectively. Interestingly, a more marked CPE was
evidenced in differentiated cells, and cytomegalic inclusions,
syncytia formation, vacuoles, and granulations were clearer. A
higher percentage of dead cells were found in the viability
assay even at 1 and 7 dpi, and the positivity for gB increased
in comparison with nondifferentiated hNS-1 cells.
The increased susceptibility to infection after differentia-
tion induction may be a consequence of changes in one or
more steps of the infection process, such as attachment, entry,
trafficking, nuclear entry, and promoter activity (Kawasaki
et al. 2011). It has been reported that the susceptibility of
mouse stem cells to CMV may be determined by the concen-
tration of heparan sulfate, presence of β1-integrin and
vimentin, and nuclear pore density (Kawasaki et al. 2011). It
is possible that one of these factors may be related to the
acquisition of susceptibility to HCMV in human cells, includ-
ing hNS-1 cells, which will be the object of further investiga-
tion. Interestingly, as the mouse embryonic stem cells are re-
fractory to the infection, differentiated neurons also have
shown an apparent refractivity (Cheeran et al. 2009). This
effect has been suggested to be explained by the expression
of the transcription factor C/EBP β and its dominant negative
isoform which binds to the enhancer region and inhibits tran-
scription from the HCMVMIEP (Cheeran et al. 2005). By this
reason, we assessed the role of differentiation in hNS-1 cells at
an early stage when some progenitors begin to differentiate
and not when the differentiated neurons can be found.
Because our main objective was to describe the earliest
effects of HCMV infection, we have used significantly lower
MOI than those employed in other reports (Cheeran et al.
2005; Odeberg et al. 2006, 2007; Luo et al. 2008, 2010).
Instead of showing the deepest impact of the infection, we
decided to monitor the progression in different time points,
in order to follow slight effects. This scheme allows us to
show that during a congenital infection, even when a low viral
dose reaches the CNS, it eventually may be able to produce
effects in the NPC.
The mechanisms that produce CNS damage during con-
genital HCMV infection have not been clearly elucidated.
However, recent efforts through in vivo and in vitro models
have allowed a better understanding of the pathogenesis of
this viral infection. It is well known that the major neurolog-
ical damage occurs during intrauterine infection by HCMVat
early pregnancy stages. In addition, some brain localizations
like ventricular and subventricular zones are particularly im-
portant; therefore, it is possible that NPCs play a substantial
role during neurological damage. Previous studies have
shown that CMV infection in NPC results in differentiation
inhibition, reduced proliferation, cellular signaling interfer-
ence, and cell death; together, these effects may produce mi-
gration defects during brain development (Kawasaki and
Tsutsui 2003; Cheeran et al. 2005; Odeberg et al. 2006; Ho
and van den Pol 2007). We developed an in vitro model using
two different NPCs promoting the use of these cell lines in-
stead of primary cultures. Permissibility to infection and di-
minished cellular viability were corroborated in the most dif-
ferentiated cell line; however, in contrast with other studies,
we found out that low viral concentrations induced cellular
proliferation in a transitory way in addition to possible differ-
entiation stimulation. Also, we verified that the permissibility
to HCMVinfection is closely related to cellular differentiation
since cells that more closely resemble neural stem cells were
less vulnerable to HCMV and they acquired susceptibility
through differentiation.
In conclusion, these experimental results can be interpreted
in the context of the observed abnormalities during a
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congenital infection. It is important to underline the impor-
tance of NPC susceptibility to HCMV because infection of
these cells may have a significant effect on fetal brain devel-
opment. Thus, both cell death and spontaneous and premature
differentiation of NPC can affect the normal proliferation and
migration patterns of neurons during fetal development lead-
ing to altered brain architecture and function. Therefore, in
order to elucidate the mechanisms and clinical consequences
of the observed effects, further investigations are required.
Acknowledgments This work was supported by grant from
CONACYT (CB16782 and #120452), PROMEP (103.5/10/7697), and
FAI-UASLP (C12-FAI-03-62.62). Hilda Gonzalez and Claudia Salazar
were recipients of scholarships from CONACYT (CVU 265757 and
265189).
Conflict of interests The authors declare that there is no conflict of
interests regarding the publication of this paper.
References
Agol VI (2012) Cytopathic effects: virus-modulated manifestations of
innate immunity? Trends Microbiol 20(12):570–576
Belec L, Mhiri C, Belghiti D, Geny C, Boudes P, Gray F (1990)
Cytomegalovirus (CMV) and human immunodeficiency virus
(HIV) co-infection, of multinucleated giant cells in acquired immu-
nodeficiency syndrome (AIDS) encephalopathy. Arch Anat Cytol
Pathol 38:189–197
Cheeran MC, Hu S, Ni HT, Sheng W, Palmquist JM, Peterson PK,
Lokensgard JR (2005) Neural precursor cell susceptibility to human
cytomegalovirus diverges along glial or neuronal differentiation
pathways. J Neurosci Res 82:839–850
Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of
congenital cytomegalovirus infection: disease mechanisms and
prospects for intervention. Clin Microbiol Rev 22:99–126,
Table of Contents
DeMarchi JM (1983) Nature of the block in the expression of some early
virus genes in cells abortively infected with human cytomegalovi-
rus. Virology 129:287–297
Griffiths PD, Grundy JE (1987) Molecular biology and immunology of
cytomegalovirus. Biochem J 241:313–324
Higgins S, Wong SH, Richner M, Rowe CL, Newgreen DF, Werther GA,
Russo VC (2009) Fibroblast growth factor 2 reactivates G1 check-
point in SK-N-MC cells via regulation of p21, inhibitor of differen-
tiation genes (Id1-3), and epithelium-mesenchyme transition-like
events. Endocrinology 150:4044–4055
Ho M (2008) The history of cytomegalovirus and its diseases. Med
Microbiol Immunol 197:65–73
Ho WS, van den Pol AN (2007) Bystander attenuation of neuronal and
astrocyte intercellular communication by murine cytomegalovirus
infection of glia. J Virol 81:7286–7292
Jafferji I, Bain M, King C, Sinclair JH (2009) Inhibition of epidermal
growth factor receptor (EGFR) expression by human cytomegalovi-
rus correlates with an increase in the expression and binding of
Wilms’ Tumour 1 protein to the EGFR promoter. J Gen Virol 90:
1569–1574
Kawasaki H, Tsutsui Y (2003) Brain slice culture for analysis of devel-
opmental brain disorders with special reference to congenital cyto-
megalovirus infection. Congenit Anom (Kyoto) 43:105–113
Kawasaki H, Kosugi I, Arai Y, Iwashita T, Tsutsui Y (2011) Mouse
embryonic stem cells inhibit murine cytomegalovirus infection
through a multi-step process. PLoS One 6:e17492
Kinzler ER, Compton T (2005) Characterization of human cytomegalo-
virus glycoprotein-induced cell-cell fusion. J Virol 79:7827–7837
Köhler TH (1995) Quantitative RT-PCR. In: Quantitation of mRNA by
polymerase chain reaction (Springer-Verlag, ed), pp 71-80 Berlin
Heidelberg
Luo MH, Schwartz PH, Fortunato EA (2008) Neonatal neural progenitor
cells and their neuronal and glial cell derivatives are fully permissive
for human cytomegalovirus infection. J Virol 82:9994–10007
Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O’Dowd JM,
Fortunato EA (2010) Human cytomegalovirus infection causes pre-
mature and abnormal differentiation of human neural progenitor
cells. J Virol 84:3528–3541
Martinez-Serrano A, Rubio FJ, Navarro B, Bueno C, Villa A (2001)
Human neural stem and progenitor cells: in vitro and in vivo prop-
erties, and potential for gene therapy and cell replacement in the
CNS. Curr Gene Ther 1(3):279–299
Matsukage S, Kosugi I, Kawasaski H, Miura K, Kitani H, Tsutsui Y
(2006) Mouse embryonic stem cells are not susceptible to cytomeg-
alovirus but acquire susceptibility during differentiation. Birth
Defects Res A Clin Mol Teratol 76:115–125
Monsivais-Urenda A, Noyola-Cherpitel D, Hernandez-Salinas A, Garcia-
Sepulveda C, Romo N, Baranda L, Lopez-Botet M, Gonzalez-
Amaro R (2010) Influence of human cytomegalovirus infection on
the NK cell receptor repertoire in children. Eur J Immunol 40:1418–
1427
Navarro-Galve B, Villa A, Bueno C, Thompson L, Johansen J, Martinez-
Serrano A (2005) Gene marking of human neural stem/precursor
cells using green fluorescent proteins. J Gene Med 7(1):18–29
Noyola DE, Jimenez-Capdeville ME, Demmler-Harrison GJ (2010)
Central nervous system disorders in infants with congenital cyto-
megalovirus infection. Neurol Res 32:278–284
Odeberg J,Wolmer N, Falci S,WestgrenM, Seiger A, Soderberg-Naucler
C (2006) Human cytomegalovirus inhibits neuronal differentiation
and induces apoptosis in human neural precursor cells. J Virol 80:
8929–8939
Odeberg J, Wolmer N, Falci S, Westgren M, Sundtrom E, Seiger A,
Soderberg-Naucler C (2007) Late human cytomegalovirus
(HCMV) proteins inhibit differentiation of human neural precursor
cells into astrocytes. J Neurosci Res 85:583–593
Ornoy A (2007) Fetal effects of primary and non-primary cytomegalovi-
rus infection in pregnancy: are we close to prevention? Isr Med
Assoc J 9:398–401
Rubio FJ, Bueno C, Villa A, Navarro B, Martinez-Serrano A (2000)
Genetically perpetuated human neural stem cells engraft and differ-
entiate into the adult mammalian brain. Mol Cell Neurosci 16:1–13
Shinmura Y, Kosugi I, Aiba-Masago S, Baba S, Yong LR, Tsutsui Y
(1997) Disordered migration and loss of virus-infected neuronal
cells in developing mouse brains infected with murine cytomegalo-
virus. Acta Neuropathol 93:551–557
Tsutsui Y (2009) Effects of cytomegalovirus infection on embryogenesis
and brain development. Congenit Anom (Kyoto) 49:47–55
Tsutsui Y, Kawasaki H, Kosugi I (2002) Reactivation of latent cytomeg-
alovirus infection in mouse brain cells detected after transfer to brain
slice cultures. J Virol 76:7247–7254
Tsutsui Y, Kosugi I, Kawasaki H, Arai Y, Han GP, Li L, Kaneta M (2008)
Roles of neural stem progenitor cells in cytomegalovirus infection of
the brain in mouse models. Pathol Int 58:257–267
van Den Pol AN, Mocarski E, Saederup N, Vieira J, Meier TJ (1999)
Cytomegalovirus cell tropism, replication, and gene transfer in
brain. J Neurosci 19:10948–10965
Villa A, Snyder EY, Vescovi A, Martinez-Serrano A (2000)
Establishment and properties of a growth factor-dependent,
356 J. Neurovirol. (2015) 21:346–357
perpetual neural stem cell line from the human CNS. Exp Neurol
161:67–84
Villa A, Rubio FJ, Navarro B, Bueno C, Martinez-Serrano A (2001)
Human neural stem cells in vitro. A focus on their isolation and
perpetuation. Biomed Pharmacother 55:91–95
Villa A, Navarro B, Martinez-Serrano A (2002) Genetic perpetu-
ation of in vitro expanded human neural stem cells: cellular
properties and therapeutic potential. Brain Res Bull 57:789–
794
Villa A, Navarro-Galve B, Bueno C, Franco S, Blasco MA, Martinez-
Serrano A (2004) Long-term molecular and cellular stability of hu-
man neural stem cell lines. Exp Cell Res 294:559–570
Wentworth BB, French L (1970) Plaque assay of cytomegalovirus strains
of human origin. Proc Soc Exp Biol Med 135:253–258
Woolf NK, Jaquish DV, Koehrn FJ (2007) Transplacental murine cyto-
megalovirus infection in the brain of SCID mice. Virol J 4:26
Wynn KK, Khanna R (2006) Models of CMV infection. Drug Discov
Today 3:91–96
J. Neurovirol. (2015) 21:346–357 357
